Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Introduction. The high cost and concern of adverse events, particularly infections, limit the use of biologic disease-modifying anti-rheumatic (bDMARD) therapies. We undertook this retrospective study to document their use for immune-mediated diseases (IMDs) and explore the efficacy, safety, adheren...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Medicine
2020
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|